Adage Capital Partners
EVH icon

Adage Capital Partners’s Evolent Health EVH Stock Holding History

Adage Capital Partners’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-160,000
Closed -$640K – 1001
2025
Q4 		$640K Sell
160,000
-28,524
-15% -$159K ﹤0.01% 861
2025
Q3 		$1.59M Sell
188,524
-100,000
-35% -$970K ﹤0.01% 819
2025
Q2 		$3.25M Sell
288,524
-93,023
-24% -$854K 0.01% 740
2025
Q1 		$3.61M Sell
381,547
-462,957
-55% -$4.68M 0.01% 729
2024
Q4 		$9.5M Sell
844,504
-575,883
-41% -$10.1M 0.02% 623
2024
Q3 		$40.2M Sell
1,420,387
-112,195
-7% -$2.89M 0.07% 276
2024
Q2 		$29.3M Buy
1,532,582
+276,176
+22% +$7.05M 0.05% 342
2024
Q1 		$41.2M Buy
1,256,406
+335,039
+36% +$10.7M 0.08% 272
2023
Q4 		$30.4M Buy
921,367
+73,599
+9% +$2.08M 0.06% 310
2023
Q3 		$23.1M Buy
847,768
+59,376
+8% +$1.65M 0.05% 354
2023
Q2 		$23.9M Buy
788,392
+379,190
+93% +$12.3M 0.05% 359
2023
Q1 		$13.3M Buy
+409,202
New +$12.9M 0.03% 546
2016
Q1 		– Sell
-100,000
Closed -$1.21M – 699
2015
Q4 		$1.21M Sell
100,000
-200,000
-67% -$2.95M ﹤0.01% 661
2015
Q3 		$4.79M Sell
300,000
-100,000
-25% -$1.95M 0.01% 618
2015
Q2 		$7.8M Buy
+400,000
New +$7.46M 0.02% 585

Other funds holding EVH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Adage Capital Partners's EVH Position: Q1 2026 in Review

Adage Capital Partners sold out of Evolent Health (EVH) in Q1 2026, closing a stake of 160,000 shares — an estimated $640K sold.

Adage Capital Partners first reported a position in EVH in Q2 2015 and held it in 15 quarters. The position peaked at $41.2M in Q1 2024. 191 funds tracked by Wall St. Rank hold EVH as of Q1 2026.

  • Adage Capital Partners reported no remaining Evolent Health position as of Q1 2026 after selling out during the quarter.
  • Adage Capital Partners sold 160,000 Evolent Health shares in Q1 2026, an estimated $640K.
  • Adage Capital Partners first reported a position in Evolent Health in Q2 2015 and held it in 15 quarters.
  • Adage Capital Partners's Evolent Health position peaked at $41.2M in Q1 2024.
  • 191 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.

Based on Adage Capital Partners's 13F filing for Q1 2026, filed 15 May 2026.